Tempest Therapeutics Ownership | Who Owns Tempest Therapeutics?


OverviewForecastFinancialsChart

Tempest Therapeutics Ownership Summary


Tempest Therapeutics is owned by 6.08% institutional investors, 36.69% insiders, and 57.23% retail investors. Versant venture management is the largest institutional shareholder, holding 6.08% of TPST shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.78% of its assets in Tempest Therapeutics shares.

TPST Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTempest Therapeutics6.08%36.69%57.23%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Versant venture management269.77K6.08%$774.25K
Blackrock550.24K2.47%$1.21M
Fmr431.93K1.67%$360.45K
Susquehanna group, llp123.42K0.48%$103.00K
Morgan stanley62.74K0.28%$137.39K
Bank of america corp /de/43.26K0.19%$94.73K
Citadel advisors29.60K0.13%$64.82K
Dimensional fund advisors lp25.08K0.11%$54.93K
Bnp paribas arbitrage, snc48.000.00%$40.00
Gsa capital partners llp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Versant venture management269.77K0.51%$774.25K
National bank of canada /fi/---
Tower research capital llc (trc)---
Engineers gate manager lp---
Gsa capital partners llp---
Blackrock550.24K-$1.21M
Parallel advisors---
Fil---
Federation des caisses desjardins du quebec---
Whittier trust---

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp123.42K-78.16K
Blackrock550.24K-42.05K
Morgan stanley62.74K-25.95K
Dimensional fund advisors lp25.08K-25.08K
Citadel advisors29.60K-16.10K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de---561.50K
Altium capital management lp---545.00K
Jane street group---493.09K
Geode capital management---433.35K
Ubs group---323.70K

New Positions

HolderShares% AssetsChangeValue
Dimensional fund advisors lp25.08K-25.08K$54.93K
Bnp paribas arbitrage, snc48.00-48.00$40.00
Global retirement partners5.00-5.00$4.00

Sold Out

HolderChange
Whittier trust-2.00
Whittier trust co of nevada-11.00
Qube research-27.00
Jpmorgan chase-77.00
Wells fargo & company/mn-98.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20251-269,772-612.07%----
Sep 30, 20251-50.00%269,772-8.70%711.75%--100.00%--
Jun 30, 20252-92.00%295,494-88.08%725.24%1-90.91%--100.00%
Mar 31, 202525-32.43%2,479,851-63.43%50.80%12-45.45%2-50.00%
Dec 31, 202420-37.50%5,473,11993.35%2117.63%13---100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv104.94K0.78%-
Vanguard Institutional Extnd Mkt Idx Tr35.20K0.26%-
Fidelity Extended Market Index24.49K0.18%2.50K
BlackRock Extended Equity Market K36.10K0.14%-15.00
iShares Micro-Cap ETF3.46K0.10%-
Spartan Extended Market Index Pool E41.04K0.09%1.93K
NT Ext Equity Mkt Idx Fd - L10.94K0.08%6.41K
Fidelity Total Market Index7.50K0.06%-
Spartan Total Market Index Pool E23.37K0.05%15.37K
Spartan Extended Market Index Pool F5.00K0.04%42.00

Recent Insider Transactions


DateNameRoleActivityValue
Aug 08, 2024Versant Venture Capital VI, L.P.-Sell$540.04K
Aug 12, 2024Versant Venture Capital VI, L.P.-Sell$426.99K
Jul 03, 2024Brady Stephen R President and CEOBuy$73.85K
Jul 02, 2024Whiting Samuel Chief Medical OfficerBuy$9.95K
Jun 28, 2024Trojanowski Justin Corporate ControllerBuy$16.20K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q1--
2024 Q322
2024 Q21-
2024 Q1--

TPST Ownership FAQ


Who Owns Tempest Therapeutics?

Tempest Therapeutics shareholders are primarily institutional investors at 6.08%, followed by 36.69% insiders and 57.23% retail investors. The average institutional ownership in Tempest Therapeutics's industry, Biotech Stocks , is 381.47%, which Tempest Therapeutics falls below.

Who owns the most shares of Tempest Therapeutics?

Tempest Therapeutics’s largest shareholders are Versant venture management (269.77K shares, 6.08%), Blackrock (550.24K shares, 2.47%), and Fmr (431.93K shares, 1.67%). Together, they hold 10.22% of Tempest Therapeutics’s total shares outstanding.

Does Blackrock own Tempest Therapeutics?

Yes, BlackRock owns 2.47% of Tempest Therapeutics, totaling 550.24K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.21M$. In the last quarter, BlackRock increased its holdings by 42.05K shares, a 8.27% change.

Who is Tempest Therapeutics’s biggest shareholder by percentage of total assets invested?

Versant venture management is Tempest Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.51% of its assets in 269.77K Tempest Therapeutics shares, valued at 774.25K$.

Who is the top mutual fund holder of Tempest Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tempest Therapeutics shares, with 0.78% of its total shares outstanding invested in 104.94K Tempest Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools